Related Experiment Video
Updated: Aug 13, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions
S Keijser1, G S Missotten, J M Bonfrer
1Department of Ophthalmology, Leiden University Medical Centre, PO Box 9600, 2300 RC, Leiden, The Netherlands.
The British Journal of Ophthalmology
|January 21, 2006
Summary
S100A1 protein expression can help distinguish conjunctival nevi from conjunctival melanoma. S100B protein aids in differentiating uveal melanoma from conjunctival melanoma, though further research is needed.
Area of Science:
- Ophthalmology
- Oncology
- Pathology
Background:
- Conjunctival lesions, including nevi, primary acquired melanosis (PAM), conjunctival melanoma, and uveal melanoma, require accurate pathological diagnosis.
- Immunohistochemical markers can aid in differentiating these entities.
Purpose of the Study:
- To evaluate the diagnostic utility of S100A1, S100A6, S100B, MelanA, and CEA in distinguishing between conjunctival nevi, PAM, conjunctival melanoma, and uveal melanoma.
- To assess the potential of these markers in the pathological differential diagnosis of conjunctival and uveal melanomas.
Main Methods:
- Immunohistochemical staining was performed on paraffin-embedded tissue sections from 18 conjunctival naevi, 14 PAM, 16 conjunctival melanomas, and 20 uveal melanomas.
- Expression levels of S100A1, S100A6, S100B, MelanA, and CEA were semiquantitatively scored.
Main Results:
- S100A1 expression was significantly higher in conjunctival melanomas (71.4%) compared to conjunctival naevi (30.6%).
- Conjunctival melanomas showed high S100A1 and S100B scores (71.4%, 62.9%), while uveal melanomas had high S100A1 but low S100B scores (88.5%, 18.5%).
- MelanA expression varied, and CEA was minimally detected across all groups.
Conclusions:
- S100A1 may serve as a marker to differentiate conjunctival naevi from conjunctival melanoma.
- S100B shows potential in distinguishing uveal melanoma from conjunctival melanoma.
- The study highlights the need for larger cohort studies to validate these findings.
